A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Takeda
National Institutes of Health Clinical Center (CC)
Disc Medicine, Inc
Memorial Sloan Kettering Cancer Center
Zhejiang Cancer Hospital
The First Hospital of Jilin University
Ossium Health, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
Centre Hospitalier Universitaire de Nice
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
University of Vermont
Apollo Therapeutics Ltd
First Affiliated Hospital of Zhejiang University
National Institutes of Health Clinical Center (CC)
Institut Pasteur du Cambodge
Qilu Pharmaceutical Co., Ltd.
Ohio State University Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Infanta Leonor University Hospital
Grit Biotechnology
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Ottawa Hospital Research Institute
Memorial Sloan Kettering Cancer Center
University Of Perugia
Affiliated Hospital of Nantong University
H. Lee Moffitt Cancer Center and Research Institute
ARCE Therapeutics, Inc.
Children's Hospital of Philadelphia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
University of Rochester
M.D. Anderson Cancer Center